Gilead's hepatitis C generics are on their way, but Epclusa's getting TV ads anyway

Gilead Sciences isn't letting a few of its own generics interfere with advertising its pan-genotypic hep C drug Epclusa. The Big Biotech is turning to TV again to promote its hep C franchise, this time with a commercial that highlights Epclusa's versatility across different strains of the disease.